The role of genetic polymorphisms of glutation-S-transferase μ1 (GSTM1) and gelatinase B (MMP9) in the risk of COPD development Source: Annual Congress 2003 - Alpha-1 antitrypsin deficiency and COPD Year: 2003
Are there serum levels of MMP-2 and MMP-9 may be markers of COPD phenotypes? Source: Annual Congress 2012 - COPD treatment and varia Year: 2012
The promoter polymorphism -1562C/T in matrix metalloproteinase-9 and COPD severity Source: Eur Respir J 2006; 28: Suppl. 50, 825s Year: 2006
The promoter polymorphism -1562C/T in matrix metalloproteinase-9 and COPD severity Source: Eur Respir Rev 2006; 15: 230-232 Year: 2006
Relationship between levels of IL-6 in the lungs in patients with idiopathic interstitial pneumonia and polymorphism -174 G / C promoter of the IL6 gene Source: Annual Congress 2010 - Recent developments of molecular pathology and functional genomics in non-neoplastic and neoplastic lung diseases Year: 2010
Plasma uteroglobin-related protein 1 (Ugrp1) levels is associated with Ugrp1 -112G/A polymorphism and the severity of asthma Source: Eur Respir J 2006; 28: Suppl. 50, 592s Year: 2006
MMP2 -1306C>T polymorphism and the enzyme plasma levels in patients with COPD Source: International Congress 2015 – Translational research in respiratory care: new findings Year: 2015
MMP-3 serum levels and MMP3 -1171insA promoter polymorphism in patients with COPD Source: International Congress 2014 – Basic and translational research in asthma and COPD Year: 2014
Impact of -1562 C/T polymorphism of MMP9 gene on COPD susceptibility in Polish patients. Source: International Congress 2014 – Genetics and environmental factors underlying asthma and COPD Year: 2014
Correlation between a polymorphism in the promotor region of MMP3 (Stromelisyn-1) and the clinical-functional history in COPD patients Source: Eur Respir J 2001; 18: Suppl. 33, 250s Year: 2001
Association of -308G/A polymorphism of TNF gene with the activity of proteases and antiproteases in sputum in COPD patients Source: Annual Congress 2008 - Advances in functional genomics of neoplastic and non-neoplastic lung diseases Year: 2008
Plasma acrolein level and myeloperoxidase gene polymorphism in COPD Source: Annual Congress 2010 - COPD: phenotyping and monitoring Year: 2010
Association of NOS3 gene polymorphisms with the activity of proteases and antiproteases in COPD patients Source: Annual Congress 2009 - Genetics in the smokers corner: from inflammation in smokers via COPD to cancer Year: 2009
A polymorphism -159C/T of CD14 gene regulates the serum soluble CD14 concentration but is not associated with asthma Source: Eur Respir J 2003; 22: Suppl. 45, 176s Year: 2003
To correlate of the NOS1 C/T polymorphism with the activity of proteases and antiproteases in the serum and sputum in chronic obstructive pulmonary disease patients Source: Eur Respir J 2006; 28: Suppl. 50, 585s Year: 2006
The genetic polymorphism of metalloproteinases MMP2, 7, 9 and MMP inhibitor TIMP2 in sarcoidosis Source: Annual Congress 2011 - Genetic and molecular background in pulmonary fibrosis Year: 2011
Increased expression of MMP-2 in COPD Source: Eur Respir J 2005; 26: Suppl. 49, 361s Year: 2005
Association of the plasma levels and gene polymorphism IL12B, IL13 with severe asthma in Siberian children Source: Virtual Congress 2021 – Biomarkers and risk factors in childhood asthma Year: 2021
Smoking, genotype and gene expression levels in COPD Source: International Congress 2014 – Personalised exposure and gene environment interactions in chronic airway disease: the exposome and epigenome Year: 2014
Association of -1082A/G polymorphism in IL-10 with susceptibility to COPD and decline in lung function Source: Annual Congress 2010 - New mechanisms in lung development, acute and chronic lung diseases Year: 2010